Analytical Techniques

Where particle size and performance really matters, Upperton have the expertise.
Drug delivery into the lung is one of the fastest growing, yet technically challenging areas of pharmaceutical development. Producing a successful pulmonary drug product requires expertise in formulation development, part...

The ability to self-administer small molecules, biologics and vaccines is highly attractive yet the knowledge and expertise necessary to rapidly develop products for this delivery route remains limited in the CDMO space. To meet this growing demand, Upperton has developed UpperNose™, a unique nasal product...

Upperton Pharma Solutions is an early phase Pharmaceutical Contract Development and Manufacturing Organisation (CDMO) with more than twenty years of experience in the development of pharmaceutical dosage forms.
We offer our clients an extensive range of services, from early feasibility to dosage form ...

We have extensive experience and know-how in the development of oral dosage forms containing spray dried powders. Tablets and capsules are the most common dry powder dosage form. However, other dosage forms such as sachets (bulk powders), vials (for reconstitution) have also be developed by the Upperton team.

There is interest in delivering molecules via devices (inhalation and nasal). Use our knowledge to engineer particles containing your drug with optimal aerodynamic properties tailored to the delivery device.

We have been successfully developing spray dried formulations for our customers for more than twenty years. Our experience spans a vast range of therapeutics from small molecule API’s to even the most sensitive and complex biologicals.

Overview brochure of Upperton Pharma Solutions. UK-based CDMO specialising in oral, nasal and pulmonary dosage forms.